A detailed history of City State Bank transactions in Novo Nordisk A S stock. As of the latest transaction made, City State Bank holds 1,170 shares of NVO stock, worth $123,165. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,170
Previous 1,170 -0.0%
Holding current value
$123,165
Previous $167,000 16.77%
% of portfolio
0.05%
Previous 0.07%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

BUY
$122.71 - $146.91 $4,908 - $5,876
40 Added 3.54%
1,170 $167,000
Q1 2024

Apr 11, 2024

BUY
$102.11 - $135.92 $102,110 - $135,920
1,000 Added 769.23%
1,130 $145,000
Q4 2023

Jan 10, 2024

BUY
$87.78 - $105.45 $4,389 - $5,272
50 Added 62.5%
130 $13,000
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $3,637 - $7,981
40 Added 100.0%
80 $7,000
Q1 2023

Apr 10, 2023

BUY
$132.34 - $159.14 $661 - $795
5 Added 14.29%
40 $6,000
Q4 2022

Jan 11, 2023

BUY
$102.55 - $135.33 $3,589 - $4,736
35 New
35 $5,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track City State Bank Portfolio

Follow City State Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of City State Bank, based on Form 13F filings with the SEC.

News

Stay updated on City State Bank with notifications on news.